Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 238-942-1 | CAS number: 14871-79-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames assay:
The test chemical did not induce mutation in the Salmonella typhimurium and Escherichia coli strains both in the presence and absence of S9 metabolic activation system and hence is not likely to be mutagenic under the conditions of the study.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Experimental data from various test chemicals
- Justification for type of information:
- Data for the target chemical is summarized based on the various test chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- WoE for the target CAS is summarized based on data from various test chemicals.
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- 2.Histidine for Salmonella typhimurium
3.Histidine for Salmonella typhimurium and tryptophan for Escherichia coli - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Remarks:
- 2
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Remarks:
- 3
- Details on mammalian cell type (if applicable):
- not specified
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- 2. the S9 mix, prepared from a liver post-mitochondrial fraction (S9 fraction) of rats induced with Aroclor 1254.
3. Aroclor-induced rat liver S-9 mix - Test concentrations with justification for top dose:
- 2. - First mutagenicity experiment with and without S9 mix: 0, 312.5, 625, 1250, 2500 and 5000 µg/plate
- Second mutagenicity experiment with and without S9 mix: 0, 625, 1250, 2500, 3750 and 5000 µg/plate
3. 20 pg- 5,000 pg/plate (2.0E-5 µg- 0.005 µg/plate) - Vehicle / solvent:
- 2. vehicle was used.
3. Not specified - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- not specified
- Positive control substance:
- not specified
- Remarks:
- 2
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- not specified
- Positive control substance:
- not specified
- Remarks:
- 3
- Details on test system and experimental conditions:
- 2. NUMBER OF REPLICATIONS:
- Number of cultures per concentration - triplicate
- Number of independent experiments - two independent experiments
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): No data
- Test substance added -1st experiment (+S9/-S9) and 2nd experiment (-S9): in agar (plate incorporation); 2nd experiment (+S9): preincubation method
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable: 60 minutes (only in second mutagenicity test with S9 mix)
- Exposure duration/duration of treatment: 48 to 72 hours
3. METHOD OF TREATMENT/ EXPOSURE: standard plate test or the preincubation test - Rationale for test conditions:
- Not specified
- Evaluation criteria:
- 2. The evaluation of the toxicity was performed based on the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn.
3. Plates were observed for an increase in the number of his+ or trp+ revertants. - Statistics:
- Not Specified
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100 and TA 102 : Study 2
- Remarks:
- 2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- other: Salmonella typhimurium TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA.: study 3
- Remarks:
- 3
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination: No precipitate was observed in the petri plates when scoring the revertants at all dose-levels.
RANGE-FINDING/SCREENING STUDIES (if applicable): A preliminary toxicity test was performed to define the dose-levels of test chemical to be used for the mutagenicity study.
Ames test:
- Signs of toxicity - No toxicity was noted towards all the strains used, both with and without S9 mix.
3. TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination: No precipitation of the test substance was found.
Ames test:
- Signs of toxicity - A weak bacteriotoxic effect was occasionally observed. - Remarks on result:
- other: No mutagenic effects were observed
- Conclusions:
- The test chemical did not induce mutation in the Salmonella typhimurium and Escherichia coli strains both in the presence and absence of S9 metabolic activation system and hence is not likely to be mutagenic under the conditions of the study.
- Executive summary:
In different studies, the given test chemical has been investigated for the mutagenic nature. The studies are as mentioned below:
In Genetic toxicity in vitro study, the given test chemical was evaluated for its mutagenic potential in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102 according to the OECD guideline 471 and the EU Method B13/14. A preliminary toxicity test was performed to define the dose-levels of test chemical to be used for the mutagenicity study. The test chemical was then tested in two independent experiments, both with and without a metabolic activation system, the S9 mix, prepared from a liver post-mitochondrial fraction (S9 fraction) of rats induced with Aroclor 1254. Both experiments were performed according to the direct plate incorporation method except for the second test with S9 mix, which was performed according to the preincubation method (60 minutes, 37 deg C). The five strains of bacteria Salmonella typhimurium: TA 1535, TA 1537, TA 98, TA 100 and TA 102 were exposed to the following dose levels of test chemical (three plates/dose-level): 312.5, 625, 1250, 2500 and 5000 ug/plate, for the first mutagenicity experiment with and without S9 mix; 625, 1250, 2500, 3750 and 5000 ug/mL for the second mutagenicity experiment with and without S9 mix. After 48 to 72 hours of incubation at 37 deg C, the revertant colonies were scored. The evaluation of the toxicity was performed based on the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn. The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria. The study was therefore considered valid. No precipitate was observed in the petri plates when scoring the revertants at all dose-levels. No toxicity was noted towards all the strains used, both with and without S9 mix. The test chemical did not induce any significant increase in the number of revertants, both with or without S9 mix, in any of the five strains. Under these experimental conditions, the given test chemical did not show any mutagenic activity in the bacterial reverse mutation assay, thus, it was considered as non-mutagenic.
Another gene mutation toxicity study was performed for the given test chemical to determine its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay. The strains tested were TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA at the dose range of 20 pg- 5,000 pg/plate ( 2.0E-5 µg- 0.005 µg/plate), tested with and without metabolic activation (Aroclor-induced rat liver S-9 mix). No precipitation of the test substance was observed. A weak bacteriotoxic effect was occasionally observed. An increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S-9 mix or after the addition of a metabolizing system. According to the results of the present study, the test chemical was considered as not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay.
Thus, based on the above summarized studies on test chemical, it can be concluded that the given test chemical did not induce mutation in the Salmonella typhimurium and Escherichia coli strains both in the presence and absence of S9 metabolic activation system and hence is not likely to be mutagenic under the conditions of the study.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Ames assay:
In different studies, the given test chemical has been investigated for the mutagenic nature. The studies are as mentioned below:
In Genetic toxicity in vitro study, the given test chemical was evaluated for its mutagenic potential in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102 according to the OECD guideline 471 and the EU Method B13/14. A preliminary toxicity test was performed to define the dose-levels of test chemical to be used for the mutagenicity study. The test chemical was then tested in two independent experiments, both with and without a metabolic activation system, the S9 mix, prepared from a liver post-mitochondrial fraction (S9 fraction) of rats induced with Aroclor 1254. Both experiments were performed according to the direct plate incorporation method except for the second test with S9 mix, which was performed according to the preincubation method (60 minutes, 37 deg C). The five strains of bacteria Salmonella typhimurium: TA 1535, TA 1537, TA 98, TA 100 and TA 102 were exposed to the following dose levels of test chemical (three plates/dose-level): 312.5, 625, 1250, 2500 and 5000 ug/plate, for the first mutagenicity experiment with and without S9 mix; 625, 1250, 2500, 3750 and 5000 ug/mL for the second mutagenicity experiment with and without S9 mix. After 48 to 72 hours of incubation at 37 deg C, the revertant colonies were scored. The evaluation of the toxicity was performed based on the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn. The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria. The study was therefore considered valid. No precipitate was observed in the petri plates when scoring the revertants at all dose-levels. No toxicity was noted towards all the strains used, both with and without S9 mix. The test chemical did not induce any significant increase in the number of revertants, both with or without S9 mix, in any of the five strains. Under these experimental conditions, the given test chemical did not show any mutagenic activity in the bacterial reverse mutation assay, thus, it was considered as non-mutagenic.
Another gene mutation toxicity study was performed for the given test chemical to determine its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay. The strains tested were TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA at the dose range of 20 pg- 5,000 pg/plate ( 2.0E-5 µg- 0.005 µg/plate), tested with and without metabolic activation (Aroclor-induced rat liver S-9 mix). No precipitation of the test substance was observed. A weak bacteriotoxic effect was occasionally observed. An increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S-9 mix or after the addition of a metabolizing system. According to the results of the present study, the test chemical was considered as not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay.
Thus, based on the above summarized studies on test chemical, it can be concluded that the given test chemical did not induce mutation in the Salmonella typhimurium and Escherichia coli strains both in the presence and absence of S9 metabolic activation system and hence is not likely to be mutagenic under the conditions of the study.
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the data available and applying weight of evidence approach, the given test chemical does not exhibit gene mutation in vitro by Ames assay. Hence, the test chemical is not likely to classify as a gene mutant as per the criteria mentioned in CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.